Alteration of Plasma Amino Acid Concentrations in Iranian Children with COVID-19

Sedigheh Shams1,2, Aileen Azari-Yam3, Moeinadin Safavi3

  • 1Pathology Department, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Insights

COVID-19 alters plasma amino acid levels, with higher levels of several amino acids and lower glutamine in patients. Low isoleucine predicts mortality in severe COVID-19 cases.

Area of Science:

  • Biochemistry
  • Immunology
  • Infectious Diseases

Background:

  • COVID-19, a global pandemic, significantly impacts the immune system and various organs.
  • Understanding metabolic alterations, such as changes in amino acid profiles, is crucial for managing COVID-19.
  • Previous research indicates potential links between disease severity and metabolic changes.

Purpose of the Study:

  • To investigate and compare free plasma amino acid levels in COVID-19 patients versus non-COVID-19 subjects.
  • To analyze amino acid level differences between critically ill (intensive care unit - ICU) and non-ICU COVID-19 patients.
  • To identify amino acid level correlations with patient outcomes, including mortality and recovery.

Main Methods:

  • Plasma samples were collected from 26 COVID-19 patients and 32 non-COVID-19 controls.
  • Amino acid concentrations were quantified and compared between groups using statistical analysis.
  • Logistic regression was employed to assess amino acid levels as predictors of mortality.

Main Results:

  • Significant elevations in glutamic acid, serine, glycine, threonine, phenylalanine, leucine, lysine, alanine, arginine, aspartic acid, and ornithine were observed in COVID-19 patients.
  • Glutamine levels were significantly lower in COVID-19 patients compared to controls.
  • Low glutamine and isoleucine levels were prevalent in ICU and expired patients, respectively. Low isoleucine was a significant predictor of mortality (P=0.02).

Conclusions:

  • Plasma amino acid concentrations are significantly altered in COVID-19 patients.
  • These metabolic changes, particularly low glutamine and isoleucine, are more pronounced in critically ill and non-surviving patients.
  • Amino acid profiling may offer insights into COVID-19 severity and patient prognosis.

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.7K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
78
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
234
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
439
Urea Cycle01:23

Urea Cycle

The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
45.7K